{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:24:30Z","timestamp":1777983870287,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Doctoral starting fund of Affiliated Hospital of Inner Mongolia Medical University","award":["2022NYFYBS014"],"award-info":[{"award-number":["2022NYFYBS014"]}]},{"name":"Youth Program of Inner Mongolia Medical University Affiliated Hospital","award":["2023NYFYGG003"],"award-info":[{"award-number":["2023NYFYGG003"]}]},{"name":"Talent Project of Inner Mongolia Medical University","award":["ZY20243120"],"award-info":[{"award-number":["ZY20243120"]}]},{"name":"Talent Project of Inner Mongolia Medical University Affiliated Hospital.","award":["xuyanan"],"award-info":[{"award-number":["xuyanan"]}]},{"name":"Chifeng Natural Science Foundation","award":["SZR2023183"],"award-info":[{"award-number":["SZR2023183"]}]},{"name":"Public Hospitals of Inner Mongolia Academy of Medical Sciences","award":["No. 2024GLLH1032"],"award-info":[{"award-number":["No. 2024GLLH1032"]}]},{"name":"Scientific research project of Inner Mongolia Medical University","award":["grant no.YKD2023MS041"],"award-info":[{"award-number":["grant no.YKD2023MS041"]}]},{"name":"Scientific research project of Inner Mongolia Medical University","award":["grant no.YKD2023MS042"],"award-info":[{"award-number":["grant no.YKD2023MS042"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["(grant no.81960560)"],"award-info":[{"award-number":["(grant no.81960560)"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18830-0","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T09:23:54Z","timestamp":1769765034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive 16s rRNA sequencing and metabolomics to investigate the effect of anticancer bioactive peptides combined with oxaliplatin on gastric cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Yanan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shucheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiabao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenyan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxun","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiulan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"5","key":"18830_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","volume":"20","author":"AP Thrift","year":"2023","unstructured":"Thrift, A. P., Wenker, T. N. & El-Serag, H. B. Global burden of gastric cancer: Epidemiological trends, risk factors, screening and prevention. Nat Rev Clin Oncol. 20(5), 338\u2013349 (2023).","journal-title":"Nat Rev Clin Oncol."},{"issue":"9","key":"18830_CR2","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/nu14091764","volume":"14","author":"E Bouras","year":"2022","unstructured":"Bouras, E. et al. Diet and risk of gastric cancer: An umbrella review. Nutrients 14(9), 1764 (2022).","journal-title":"Nutrients"},{"issue":"2","key":"18830_CR3","doi-asserted-by":"publisher","DOI":"10.2196\/14359","volume":"6","author":"A Aqel","year":"2020","unstructured":"Aqel, A., Khader, Y., Arqoub, K. & Nimri, O. Survival rate of gastric cancer patients in Jordan: Secondary data analysis. JMIR Public Health Surveill. 6(2), e14359 (2020).","journal-title":"JMIR Public Health Surveill."},{"issue":"4","key":"18830_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jamcollsurg.2020.12.023","volume":"232","author":"Y Woo","year":"2021","unstructured":"Woo, Y. et al. Tumor epigenetic signature and survival in resected gastric cancer patients. J Am. Coll. Surg. 232(4), 483\u2013491 (2021).","journal-title":"J Am. Coll. Surg."},{"issue":"4","key":"18830_CR5","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1002\/ags3.12439","volume":"5","author":"K Yamashita","year":"2021","unstructured":"Yamashita, K., Hosoda, K., Niihara, M. & Hiki, N. History and emerging trends in chemotherapy for gastric cancer. Ann. Gastroenterol. Surg. 5(4), 446\u2013456 (2021).","journal-title":"Ann. Gastroenterol. Surg."},{"issue":"4","key":"18830_CR6","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00280-020-04143-8","volume":"86","author":"C Teng","year":"2020","unstructured":"Teng, C. et al. Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: A pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer. Cancer Chemother Pharmacol. 86(4), 547\u2013558 (2020).","journal-title":"Cancer Chemother Pharmacol."},{"issue":"3","key":"18830_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1515\/dmpt-2021-0162","volume":"37","author":"DS Fedorinov","year":"2021","unstructured":"Fedorinov, D. S., Lyadov, V. K. & Sychev, D. A. Genotype-based chemotherapy for patients with gastrointestinal tumors: Focus on oxaliplatin, irinotecan, and fluoropyrimidines. Drug Metab. Pers. Ther. 37(3), 223\u2013228 (2021).","journal-title":"Drug Metab. Pers. Ther."},{"issue":"4","key":"18830_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00280-018-3652-2","volume":"82","author":"K Yamaguchi","year":"2018","unstructured":"Yamaguchi, K. et al. The risk factors for oxaliplatin-induced peripheral sensory neuropathy and thrombocytopenia in advanced gastric cancer. Cancer Chemother. Pharmacol. 82(4), 625\u2013633 (2018).","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"4","key":"18830_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/jcb.24711","volume":"115","author":"L Yu","year":"2014","unstructured":"Yu, L., Yang, L., An, W. & Su, X. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by suppressing gastric cancer stem cells. J. Cell Biochem. 115(4), 697\u2013711 (2014).","journal-title":"J. Cell Biochem."},{"issue":"10","key":"18830_CR10","doi-asserted-by":"publisher","first-page":"10051","DOI":"10.1007\/s13277-014-2272-7","volume":"35","author":"LY Su","year":"2014","unstructured":"Su, L. Y. et al. Anticancer bioactive peptide (ACBP) inhibits gastric cancer cells by upregulating growth arrest and DNA damage-inducible gene 45A (GADD45A). Tumour Biol. 35(10), 10051\u201310056 (2014).","journal-title":"Tumour Biol."},{"issue":"1","key":"18830_CR11","first-page":"3","volume":"23","author":"L Su","year":"2010","unstructured":"Su, L. et al. Anticancer bioactive peptide suppresses human gastric cancer growth through modulation of apoptosis and the cell cycle. Oncol. Rep. 23(1), 3\u20139 (2010).","journal-title":"Oncol. Rep."},{"issue":"1","key":"18830_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-3701-4-7","volume":"4","author":"X Su","year":"2014","unstructured":"Su, X. et al. Combination therapy of anti-cancer bioactive peptide with Cisplatin decreases chemotherapy dosing and toxicity to improve the quality of life in xenograft nude mice bearing human gastric cancer. Cell Biosci. 4(1), 7 (2014).","journal-title":"Cell Biosci."},{"issue":"6","key":"18830_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13578-016-0112-8","volume":"22","author":"Z Xing","year":"2016","unstructured":"Xing, Z., Yu, L., Li, X. & Su, X. Anticancer bioactive peptide-3 inhibits human gastric cancer growth by targeting miR-338-5p. Cell Biosci. 22(6), 53 (2016).","journal-title":"Cell Biosci."},{"issue":"1","key":"18830_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3892\/or.2017.5674","volume":"38","author":"X Li","year":"2017","unstructured":"Li, X., Wu, H., Ouyang, X., Zhang, B. & Su, X. New bioactive peptide reduces the toxicity of chemotherapy drugs and increases drug sensitivity. Oncol. Rep. 38(1), 129\u2013140 (2017).","journal-title":"Oncol. Rep."},{"issue":"1","key":"18830_CR15","first-page":"201","volume":"43","author":"Y Xu","year":"2020","unstructured":"Xu, Y., Li, X. & Su, X. iTRAQ-based proteomics analysis of the therapeutic effects of combined anticancer bioactive peptides and oxaliplatin on gastric cancer cells. Oncol. Rep. 43(1), 201\u2013217 (2020).","journal-title":"Oncol. Rep."},{"issue":"12","key":"18830_CR16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/s41419-021-04396-y","volume":"12","author":"D Dai","year":"2021","unstructured":"Dai, D. et al. Interactions between gastric microbiota and metabolites in gastric cancer. Cell Death Dis. 12(12), 1104 (2021).","journal-title":"Cell Death Dis."},{"issue":"21","key":"18830_CR17","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1093\/bioinformatics\/btr507","volume":"27","author":"T Mago\u010d","year":"2011","unstructured":"Mago\u010d, T. & Salzberg, S. L. FLASH: Fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27(21), 2957\u20132963 (2011).","journal-title":"Bioinformatics"},{"issue":"1","key":"18830_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nmeth.2276","volume":"10","author":"NA Bokulich","year":"2013","unstructured":"Bokulich, N. A. et al. Quality-filtering vastly improves diversity estimates from Illuminaamplicon sequencing. Nat. Methods 10(1), 57\u201359 (2013).","journal-title":"Nat. Methods"},{"issue":"5","key":"18830_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7(5), 335\u2013336 (2010).","journal-title":"Nat. Methods"},{"issue":"16","key":"18830_CR20","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","volume":"27","author":"RC Edgar","year":"2011","unstructured":"Edgar, R. C. et al. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27(16), 2194\u20132200 (2011).","journal-title":"Bioinformatics"},{"issue":"3","key":"18830_CR21","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1101\/gr.112730.110","volume":"21","author":"BJ Haas","year":"2011","unstructured":"Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21(3), 494\u2013504 (2011).","journal-title":"Genome Res."},{"issue":"10","key":"18830_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar, R. C. UPARSE: Highly accurate OTU sequences from microbial amplicon reads. Nat. Methods 10(10), 996\u2013998 (2013).","journal-title":"Nat. Methods"},{"issue":"4","key":"18830_CR23","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.molcel.2016.04.002","volume":"62","author":"R Aviram","year":"2016","unstructured":"Aviram, R. et al. Lipidomics analyses reveal temporal and spatial lipid organization and uncover daily oscillations in intracellular organelles. Mol Cell. 62(4), 636\u2013648 (2016).","journal-title":"Mol Cell."},{"issue":"2","key":"18830_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/metabo8020031","volume":"8","author":"I Bla\u017eenovi\u0107","year":"2018","unstructured":"Bla\u017eenovi\u0107, I., Kind, T., Ji, J. & Fiehn, O. Software tools and approaches for compound identification of LC-MS\/MS data in metabolomics. Metabolites 8(2), 31 (2018).","journal-title":"Metabolites"},{"key":"18830_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11306-012-0434-4","volume":"9","author":"WB Dunn","year":"2012","unstructured":"Dunn, W. B. et al. Mass appeal: Metabolite identification in mass spectrometry-focused untargeted metabolomics. Metabolomics 9, 44\u201366 (2012).","journal-title":"Metabolomics"},{"issue":"3","key":"18830_CR26","first-page":"264","volume":"71","author":"SS Joshi","year":"2021","unstructured":"Joshi, S. S. & Badgwell, B. D. Current treatment and recent progress in gastric cancer. CA Cancer J. Clin. 71(3), 264\u2013279 (2021).","journal-title":"CA Cancer J. Clin."},{"issue":"72","key":"18830_CR27","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-med-051019-103216","volume":"27","author":"ND Pilonis","year":"2021","unstructured":"Pilonis, N. D., Tischkowitz, M., Fitzgerald, R. C. & di Pietro, M. Hereditary diffuse gastric cancer: Approaches to screening, surveillance, and treatment. Annu. Rev. Med. 27(72), 263\u2013280 (2021).","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"18830_CR28","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3390\/ijerph20032149","volume":"20","author":"CB Conti","year":"2023","unstructured":"Conti, C. B. et al. Early gastric cancer: Update on prevention, diagnosis and treatment. Int. J. Environ. Res. Public Health 20(3), 2149 (2023).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"1","key":"18830_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan, W. L., He, Y. & Xu, R. H. Gastric cancer treatment: Recent progress and future perspectives. J. Hematol. Oncol. 16(1), 57 (2023).","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"18830_CR30","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.3390\/nu11112605","volume":"11","author":"S Fern\u00e1ndez-Tom\u00e9","year":"2019","unstructured":"Fern\u00e1ndez-Tom\u00e9, S. et al. Immunomodulatory effect of gut microbiota-derived bioactive peptides on human immune system from healthy controls and patients with inflammatory bowel disease. Nutrients 11(11), 2605 (2019).","journal-title":"Nutrients"},{"issue":"1","key":"18830_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191063","volume":"13","author":"AE Nardo","year":"2018","unstructured":"Nardo, A. E., A\u00f1\u00f3n, M. C. & Parisi, G. Large-scale mapping of bioactive peptides in structural and sequence space. PLoS ONE 13(1), e0191063 (2018).","journal-title":"PLoS ONE"},{"issue":"5","key":"18830_CR32","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1021\/acs.jmedchem.3c02232","volume":"67","author":"XY Fu","year":"2024","unstructured":"Fu, X. Y. et al. Three rounds of stability-guided optimization and systematical evaluation of oncolytic peptide LTX-315. J. Med. Chem. 67(5), 3885\u20133908 (2024).","journal-title":"J. Med. Chem."},{"issue":"1","key":"18830_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41401-022-00939-x","volume":"44","author":"H Yin","year":"2023","unstructured":"Yin, H. et al. The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus. Acta Pharmacol. Sin. 44(1), 201\u2013210 (2023).","journal-title":"Acta Pharmacol. Sin."},{"key":"18830_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106674","volume":"138","author":"H Yin","year":"2023","unstructured":"Yin, H. et al. Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates. Bioorg. Chem. 138, 106674 (2023).","journal-title":"Bioorg. Chem."},{"issue":"3","key":"18830_CR35","first-page":"1917","volume":"20","author":"X Li","year":"2020","unstructured":"Li, X., Gao, B. & Su, X. Anticancer bioactive peptide combined with docetaxel and its mechanism in the treatment of breast cancer. Exp. Ther. Med. 20(3), 1917\u20131924 (2020).","journal-title":"Exp. Ther. Med."},{"issue":"12","key":"18830_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.960281","volume":"23","author":"C Lei","year":"2022","unstructured":"Lei, C., Gong, D., Zhuang, B. & Zhang, Z. Alterations in the gastric microbiota and metabolites in gastric cancer: An update review. Front. Oncol. 23(12), 960281 (2022).","journal-title":"Front. Oncol."},{"issue":"Pt 3","key":"18830_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.semcancer.2022.05.001","volume":"86","author":"E Bess\u00e8de","year":"2022","unstructured":"Bess\u00e8de, E. & M\u00e9graud, F. Microbiota and gastric cancer. Semin. Cancer Biol. 86(Pt 3), 11\u201317 (2022).","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"18830_CR38","doi-asserted-by":"publisher","first-page":"1105811","DOI":"10.3389\/fcimb.2022.1105811","volume":"10","author":"Y Guo","year":"2023","unstructured":"Guo, Y., Cao, X. S., Zhou, M. G. & Yu, B. Gastric microbiota in gastric cancer: Different roles of Helicobacter pylori and other microbes. Front. Cell Infect. Microbiol. 10(12), 1105811 (2023).","journal-title":"Front. Cell Infect. Microbiol."},{"issue":"1","key":"18830_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12967-022-03650-x","volume":"20","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Microbiota and metabolites alterations in proximal and distal gastric cancer patients. J. Transl. Med. 20(1), 439 (2022).","journal-title":"J. Transl. Med."},{"issue":"9","key":"18830_CR40","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1136\/gutjnl-2019-319696","volume":"69","author":"Y Guo","year":"2020","unstructured":"Guo, Y. et al. Effect of Helicobacter pylori on gastrointestinal microbiota: A population-based study in Linqu, a high-risk area of gastric cancer. Gut 69(9), 1598\u20131607 (2020).","journal-title":"Gut"},{"issue":"2022","key":"18830_CR41","first-page":"9971619","volume":"28","author":"Y Miao","year":"2022","unstructured":"Miao, Y. et al. Gut microbiota dysbiosis in the development and progression of gastric cancer. J. Oncol. 28(2022), 9971619 (2022).","journal-title":"J. Oncol."},{"issue":"48","key":"18830_CR42","doi-asserted-by":"publisher","first-page":"34956","DOI":"10.1074\/jbc.M113.516153","volume":"288","author":"SA Shiryaev","year":"2013","unstructured":"Shiryaev, S. A. et al. Substrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface. J. Biol. Chem. 288(48), 34956\u201334967 (2013).","journal-title":"J. Biol. Chem."},{"issue":"9","key":"18830_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fonc.2019.00608","volume":"9","author":"Z Dong","year":"2019","unstructured":"Dong, Z. et al. Detection of microbial 16S rRNA gene in the serum of patients with gastric cancer. Front. Oncol. 9(9), 608 (2019).","journal-title":"Front. Oncol."},{"issue":"1","key":"18830_CR44","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s10930-021-10029-2","volume":"41","author":"MR Salaikumaran","year":"2022","unstructured":"Salaikumaran, M. R., Badiger, V. P. & Burra, V. L. S. P. S rRNA methyltransferases as novel drug targets against tuberculosis. Protein J. 41(1), 97\u2013130 (2022).","journal-title":"Protein J."},{"key":"18830_CR45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/978-1-0716-2871-3_10","volume":"2605","author":"S Comtet-Marre","year":"2023","unstructured":"Comtet-Marre, S., Chakoory, O. & Peyret, P. Targeted 16S rRNA gene capture by hybridization and bioinformatic analysis. Methods Mol. Biol. 2605, 187\u2013208 (2023).","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"18830_CR46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1265\/jjh.65.422","volume":"65","author":"A Kawano","year":"2010","unstructured":"Kawano, A., Ishikawa, H., Nakamura, T. & Kono, K. Evaluation of epidemiological studies of intestinal bacteria that affected occurrence of colorectal cancer: Studies of prevention of colorectal tumors by dairy products and lactic acid bacteria. Nihon Eiseigaku Zasshi. 65(3), 422\u2013446 (2010).","journal-title":"Nihon Eiseigaku Zasshi."},{"issue":"3","key":"18830_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00253-012-4575-1","volume":"97","author":"P Ribelles","year":"2013","unstructured":"Ribelles, P., Benbouziane, B., Langella, P., Su\u00e1rez, J. E. & Berm\u00fadez-Humar\u00e1n, L. G. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface. Appl. Microbiol. Biotechnol. 97(3), 1231\u20131239 (2013).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"18830_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154394","volume":"106","author":"X Li","year":"2022","unstructured":"Li, X. et al. Sanguinarine ameliorates DSS induced ulcerative colitis by inhibiting NLRP3 inflammasome activation and modulating intestinal microbiota in C57BL\/6 mice. Phytomedicine 106, 154394 (2022).","journal-title":"Phytomedicine"},{"issue":"1","key":"18830_CR49","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1038\/s41467-022-31171-0","volume":"13","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery. Nat Commun. 13(1), 3432 (2022).","journal-title":"Nat Commun."},{"issue":"10","key":"18830_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1472-6793-10-19","volume":"8","author":"PA Watkins","year":"2010","unstructured":"Watkins, P. A. et al. Identification of differences in human and great ape phytanic acid metabolism that could influence gene expression profiles and physiological functions. BMC Physiol. 8(10), 19 (2010).","journal-title":"BMC Physiol."},{"issue":"5","key":"18830_CR51","doi-asserted-by":"publisher","first-page":"260","DOI":"10.18821\/0869-2084-2019-64-5-260-264","volume":"64","author":"TN Pogorelova","year":"2019","unstructured":"Pogorelova, T. N. et al. The activity of enzymes of amino acid metabolism of the placenta in different terms of the physiological and complicated pregnancy. Klin. Lab. Diagn. 64(5), 260\u2013264 (2019).","journal-title":"Klin. Lab. Diagn."},{"issue":"9\u201310","key":"18830_CR52","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s10495-023-01875-9","volume":"28","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. The regulation of amino acid metabolism in tumor cell death: From the perspective of physiological functions. Apoptosis 28(9\u201310), 1304\u20131314 (2023).","journal-title":"Apoptosis"},{"issue":"1","key":"18830_CR53","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00726-008-0210-y","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu, G. et al. Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37(1), 153\u2013168 (2009).","journal-title":"Amino Acids"},{"issue":"12","key":"18830_CR54","doi-asserted-by":"publisher","first-page":"2579S","DOI":"10.3945\/jn.115.226621","volume":"146","author":"SM Morris Jr","year":"2016","unstructured":"Morris, S. M. Jr. Arginine metabolism revisited. J. Nutr. 146(12), 2579S-2586S (2016).","journal-title":"J. Nutr."},{"issue":"14","key":"18830_CR55","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3390\/cancers13143541","volume":"13","author":"CL Chen","year":"2021","unstructured":"Chen, C. L., Hsu, S. C., Ann, D. K., Yen, Y. & Kung, H. J. Arginine signaling and cancer metabolism. Cancers (Basel). 13(14), 3541 (2021).","journal-title":"Cancers (Basel)."},{"issue":"5","key":"18830_CR56","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s00726-017-2399-0","volume":"49","author":"X Ma","year":"2017","unstructured":"Ma, X. et al. L-Arginine promotes protein synthesis and cell growth in brown adipocyte precursor cells via the mTOR signal pathway. Amino Acids 49(5), 957\u2013964 (2017).","journal-title":"Amino Acids"},{"issue":"2","key":"18830_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2023.152344","volume":"228","author":"JT Mammedova","year":"2023","unstructured":"Mammedova, J. T. et al. Streptococcal arginine deiminase regulates endothelial inflammation, mTOR pathway and autophagy. Immunobiology 228(2), 152344 (2023).","journal-title":"Immunobiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18830-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18830-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:05:03Z","timestamp":1770030303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18830-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["18830"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18830-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6875583\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal experiments were approved by the Institutional Animal Care and Use Committee of Inner Mongolia Medical University Publisher\u2019s note (YKD2019224).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"4314"}}